Cargando…

Elasomeran+davesomeran for prevention of COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Guidelines 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665087/
http://dx.doi.org/10.18773/austprescr.2023.018
_version_ 1785148829705699328
collection PubMed
description
format Online
Article
Text
id pubmed-10665087
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Therapeutic Guidelines
record_format MEDLINE/PubMed
spelling pubmed-106650872023-12-05 Elasomeran+davesomeran for prevention of COVID-19 Aust Prescr New Drug Therapeutic Guidelines 2023-10-24 2023-10 /pmc/articles/PMC10665087/ http://dx.doi.org/10.18773/austprescr.2023.018 Text en (c) Therapeutic Guidelines https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drug
Elasomeran+davesomeran for prevention of COVID-19
title Elasomeran+davesomeran for prevention of COVID-19
title_full Elasomeran+davesomeran for prevention of COVID-19
title_fullStr Elasomeran+davesomeran for prevention of COVID-19
title_full_unstemmed Elasomeran+davesomeran for prevention of COVID-19
title_short Elasomeran+davesomeran for prevention of COVID-19
title_sort elasomeran+davesomeran for prevention of covid-19
topic New Drug
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665087/
http://dx.doi.org/10.18773/austprescr.2023.018